ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ramón Rami-Porta
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mateu-Navarro, M.
Right arrow Articles by González-Pont, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mateu-Navarro, M.
Right arrow Articles by González-Pont, G.

Ann Thorac Surg 2000;70:391-395
© 2000 The Society of Thoracic Surgeons


Original articles: general thoracic

Remediastinoscopy after induction chemotherapy in non-small cell lung cancer

Miquel Mateu-Navarro, MDa, Ramón Rami-Porta, MDa, Romà Bastus-Piulats, MDb, Luis Cirera-Nogueras, MDb, Guadalupe González-Pont, MDc

a Sections of Thoracic Surgery, Hospital Mútua de Terrassa, University of Barcelona, Terrassa, Barcelona, Spain
b Oncology, Hospital Mútua de Terrassa, University of Barcelona, Terrassa, Barcelona, Spain
c Department of Pathology, Hospital Mútua de Terrassa, University of Barcelona, Terrassa, Barcelona, Spain

Address reprint requests to Dr Mateu-Navarro, Section of Thoracic Surgery, Hospital Mutua de Terrassa, Calle Sant Antoni 8-14, 08221 Terrassa, Barcelona, Spain
e-mail: 10838mmn{at}comb.es

Background. This study was undertaken to evaluate the technical feasibility and the sensitivity, specificity, and accuracy of remediastinoscopy in restaging N2 bronchogenic carcinoma treated with neoadjuvant chemotherapy.

Methods. Patients presenting mediastinal lymph node involvement at mediastinoscopy received three or four cycles of neoadjuvant chemotherapy with mitomycin, iphosphamide, and cisplatin or cisplatin and gemcitabine. If there was no disease progression, these patients underwent remediastinoscopy and, if no residual extracapsular involvement or N3 disease was found, a thoracotomy was then carried out.

Results. Twenty-four patients underwent remediastinoscopy. In 12 (50%) remediastinoscopy was positive. The 12 remaining patients were operated on and the tumors resected: 5 pneumonectomies and 7 lobectomies. Lymphadenectomy specimens showed residual disease in mediastinal lymph nodes in 5 patients (pN2) and hilar lymph nodes in 1 patient (pN1). The other 6 patients were free of nodal disease, and 4 of them presented no involvement at lung level either. The sensitivity, specificity, and accuracy of remediastinoscopy were 0.7, 1, and 0.8, respectively.

Conclusions. Remediastinoscopy is a technically feasible staging tool with high diagnostic accuracy that is useful in the selection of patients who can be served best by complete resection after neoadjuvant chemotherapy.




This article has been cited by other articles:


Home page
JCOHome page
F. J.F. Herth, J. T. Annema, R. Eberhardt, K. Yasufuku, A. Ernst, M. Krasnik, and R. C. Rintoul
Endobronchial Ultrasound With Transbronchial Needle Aspiration for Restaging the Mediastinum in Lung Cancer
J. Clin. Oncol., July 10, 2008; 26(20): 3346 - 3350.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. De Waele, M. Serra-Mitjans, J. Hendriks, P. Lauwers, J. Belda-Sanchis, P. Van Schil, and R. Rami-Porta
Accuracy and survival of repeat mediastinoscopy after induction therapy for non-small cell lung cancer in a combined series of 104 patients
Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 824 - 828.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. E. Van Schil and M. De Waele
A second mediastinoscopy: how to decide and how to do it?
Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 703 - 706.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Marra, L. Hillejan, S. Fechner, and G. Stamatis
Remediastinoscopy in restaging of lung cancer after induction therapy.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 843 - 849.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. De Leyn, D. Lardinois, P. E. Van Schil, R. Rami-Porta, B. Passlick, M. Zielinski, D. A. Waller, T. Lerut, and W. Weder
ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer
Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Z. Mansour, E. A. Kochetkova, X. Ducrocq, M.-D. Vasilescu, G. Maxant, A. Buggenhout, J.-M. Wihlm, and G. Massard
Induction chemotherapy does not increase the operative risk of pneumonectomy!
Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 181 - 185.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. De Leyn, S. Stroobants, W. De Wever, T. Lerut, W. Coosemans, G. Decker, P. Nafteux, D. Van Raemdonck, L. Mortelmans, K. Nackaerts, et al.
Prospective Comparative Study of Integrated Positron Emission Tomography-Computed Tomography Scan Compared With Remediastinoscopy in the Assessment of Residual Mediastinal Lymph Node Disease After Induction Chemotherapy for Mediastinoscopy-Proven Stage IIIA-N2 Non-Small-Cell Lung Cancer: A Leuven Lung Cancer Group Study
J. Clin. Oncol., July 20, 2006; 24(21): 3333 - 3339.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Cerfolio, A. S. Bryant, and B. Ojha
Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: A prospective study
J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1229 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Plat, P. Pierard, A. Haller, J. Hutsebaut, J. Faber, M. Dusart, P. Eisendrath, J-P. Sculier, and V. Ninane
Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes
Eur. Respir. J., February 1, 2006; 27(2): 276 - 281.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. De Waele, J. Hendriks, P. Lauwers, P. Ortmanns, W. Vanroelen, A.-M. Morel, P. Germonpre, and P. Van Schil
Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy
Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 240 - 243.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. M. DeCamp Jr., S. Ashiku, and R. Thurer
The Role of Surgery in N2 Non-Small Cell Lung Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 5033s - 5037s.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. L. Port, M. S. Kent, R. J. Korst, R. Keresztes, M. A. Levin, and N. K. Altorki
Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer
Ann. Thorac. Surg., January 1, 2004; 77(1): 254 - 259.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. C.M. Pitz, K. W. Maas, H. A. V. Swieten, A. Brutel de la Riviere, P. Hofman, and F. M.N.H. Schramel
Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer
Ann. Thorac. Surg., July 1, 2002; 74(1): 164 - 169.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Akhurst, R. J. Downey, M. S. Ginsberg, M. Gonen, M. Bains, R. Korst, R. J. Ginsberg, V. W. Rusch, and S. M. Larson
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer
Ann. Thorac. Surg., January 1, 2002; 73(1): 259 - 266.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.